CrossrefInfokarte
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study
Clinical Pharmacology: Advances and Applications · 2021-06 · Volume 13 · 123-134
DOI: 10.2147/cpaa.s305308 ↗Abstract
Kein Abstract verfügbar.
EUVIMED